Regeneration of Furcation Defects Treated with Porous Hydroxyapatite and Platelet-Rich Plasma: A Histological Study
Introduction The alveolar bone, periodontal ligament (PDL), and cementum are the integral structural components invariably subject to changes during periodontal diseases. Many documents on animal and human studies state that the polypeptide growth factors (GFs) have a role in periodontal regeneration. The platelet-rich fibrin (PRF) is in use since the last decade. It has the potential of delivering GFs into vertical osseous defects. Human platelets contain platelet-derived growth factor and transforming growth factor-β in their α granules. These GFs are involved in wound healing and act as promoters of tissue regeneration. The study aimed to obtain histologic evidence, if any, of new attachment in humans, following treatment of osseous defects with 10-1055-s-0040-1714651_00084_ (HA) and PRF mix.
Materials and Methods Five maxillary molar teeth with advanced bone loss were treated with porous 10-1055-s-0040-1714651_00084_ (PHA) mixed with PRF. Distobuccal roots were resected and studied histologically for evidence of bone formation, if any, at 1st, 3rd, and the 5th months.
Results The PHA was completely resorbed in all the specimens. There was definitive evidence of bone formation at the 3rd month itself with mature lamellar bone with resting and reversal lines at the fifth postoperative month. There was no evidence of new cementum or PDL formation.
Conclusion PRF in conjunction with osteoconductive materials prove to accelerate bone formation in vertical osseous defects.
03 August 2020 (online)
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
- 1 Garrett S. Periodontal regeneration around natural teeth. Ann Periodontol 1996; 1 (01) 621-666
- 2 Mellonig JT. Autogenous and allogeneic bone grafts in periodontal therapy. Crit Rev Oral Biol Med 1992; 3 (04) 333-352
- 3 Bowers GM, Chadroff B, Carnevale R. et al. Histologic evaluation of new attachment apparatus formation in humans. Part II. J Periodontol 1989; 60 (12) 675-682
- 4 Kenney EB, Lekovic V, Sa Ferreira JC, Han T, Dimitrijevic B, Carranza Jr FA. Bone formation within porous hydroxylapatite implants in human periodontal defects. J Periodontol 1986; 57 (02) 76-83
- 5 Stahl SS, Froum SJ. Histologic and clinical responses to porous hydroxylapatite implants in human periodontal defects. Three to twelve months postimplantation. J Periodontol 1987; 58 (10) 689-695
- 6 West TL, Brustein DD. Freeze-dried bone and coralline implants compared in the dog. J Periodontol 1985; 56 (06) 348-351
- 7 Martin RB, Chapman MW, Holmes RE. et al. Effects of bone ingrowth on the strength and non-invasive assessment of a coralline 10-1055-s-0040-1714651_00084_ material. Biomaterials 1989; 10 (07) 481-488
- 8 McCauley LK, Somerman MJ, Biological modifiers in periodontal regeneration. Advances in Periodontics, Part-1. In: Vandersall DC, ed. Dental Clinics of North America. April 1998; 42(2): 361–387
- 9 Gamal AY, Mailhot JM. The effect of local delivery of PDGF-BB on attachment of human periodontal ligament fibroblasts to periodontitis-affected root surfaces–in vitro. J Clin Periodontol 2000; 27 (05) 347-353
- 10 Giannobile WV, Hernandez RA, Finkelman RD. et al. Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis. J Periodontal Res 1996; 31 (05) 301-312
- 11 Howell TH, Fiorellini JP, Paquette DW, Offenbacher S, Giannobile WV, Lynch SE. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol 1997; 68 (12) 1186-1193
- 12 Lynch SE, de Castilla GR, Williams RC. et al. The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. J Periodontol 1991; 62 (07) 458-467
- 13 Lynch SE, Williams RC, Polson AM. et al. A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J Clin Periodontol 1989; 16 (08) 545-548
- 14 Takayama S, Murakami S, Miki Y. et al. Effects of basic fibroblast growth factor on human periodontal ligament cells. J Periodontal Res 1997; 32 (08) 667-675
- 15 Rutherford RB, Niekrash CE, Kennedy JE, Charette MF. Platelet-derived and insulin-like growth factors stimulate regeneration of periodontal attachment in monkeys. J Periodontal Res 1992; 27 (4 Pt 1) 285-290
- 16 Lynch SE. Introduction. In: Lynch SE, Genco RJ, Marx RE. eds. Tissue Engineering Applications in Maxillofacial Surgery and Periodontics. Chicago: Quintessence Publishing Co, Inc; 1999: xi-xviii
- 17 Sonnleitner D, Huemer P, Sullivan DY. A simplified technique for producing platelet-rich plasma and platelet concentrate for intraoral bone grafting techniques: a technical note. Int J Oral Maxillofac Implants 2000; 15 (06) 879-882
- 18 Nevins M, Camelo M, Nevins ML, Schenk RK, Lynch SE. Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone. J Periodontol 2003; 74 (09) 1282-1292
- 19 Murphy WL, Mooney DJ. Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices. J Periodontal Res 1999; 34 (07) 413-419
- 20 Yao F, Eriksson E. Gene therapy in wound repair and regeneration. Wound Repair Regen 2000; 8 (06) 443-451
- 21 Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet rich plasma: growth factor enhancement for grafts. Oral Surg Oral Med Oral Pathol Radiol Endod 1998; 85 (06) 638-646
- 22 Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP?. Implant Dent 2001; 10 (04) 225-228
- 23 Siebrecht MA, De PP Rooij, Arm DM, Olsson ML, Aspenberg P. Platelet concentrate increases bone ingrowth into porous 10-1055-s-0040-1714651_00084_. Orthopedics 2002; 25 (02) 169-172
- 24 Lekovic V, Camargo PM, Weinlaender M, Vasilic N, Kenney EB. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study. J Periodontol 2002; 73 (02) 198-205
- 25 Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999; 14 (04) 529-535
- 26 Landesberg R, Moses M, Karpapkin M. Risks of using platelet rich plasma gel. To the editor. J Oral Maxillofac Surg 1998; 56: 116-117
- 27 Carranza Jr FA, Kenney EB, Lekovic V, Talamante E, Valencia J, Dimitrijevic B. Histologic study of healing of human periodontal defects after placement of porous hydroxylapatite implants. J Periodontol 1987; 58 (10) 682-688
- 28 Hartwig D, Härtel C, Hennig H, Müller-Steinhardt M, Schlenke P, Klüter H. Evidence for de novo synthesis of cytokines and chemokines in platelet concentrates. Vox Sang 2002; 82 (04) 182-190
- 29 Kubota K, Sakikawa C, Katsumata M, Nakamura T, Wakabayashi K. Platelet-derived growth factor BB secreted from osteoclasts acts as an osteoblastogenesis inhibitory factor. J Bone Miner Res 2002; 17 (02) 257-265
- 30 Bowen-Pope DF, Malpass TW, Foster DM, Ross R. Platelet-derived growth factor in vivo: levels, activity, and rate of clearance. Blood 1984; 64 (02) 458-469